Introduction
============

Autophagy is a cellular degradation mechanism characterized by the formation of double membrane cytoplasmic vesicles, which engulf and degrade cytoplasmic organelles such as mitochondria or ER through lysosomes, thereby, regulate normal cellular integrity and homeostasis of cells. Genetic deletion of Atg has revealed the roles of autophagy in response to cellular differentiation, development, homeostasis, starvation, and stressful conditions ([@B29]). Mice models with deletion of Atg genes has revealed the correlation between autophagy and diseases including neurodegenerative diseases, infectious diseases, metabolic diseases, and cancers ([@B19]). In cancers therapies, autophagy can act as either a tumor suppressor by the removal of damaged proteins and organelles, or as a pro-survival mechanism to promote the pathogenesis of tumors ([@B63]). For example, constitutive activation of autophagy could eventually lead to autophagic cell death (type II programmed cell death) ([@B52]). Monoallelic loss of the essential autophagy gene, beclin 1, were found in human breast, prostate, and ovarian cancers, suggesting the role of autophagy in preventing tumorigenesis ([@B63]). However, resistant to apoptosis remains a major obstacle in cancer therapies. Emerging evidence have reported novel compounds such as polyphenolic natural compounds curcumin, rottlerin, quercetin, genistein and resveratrol ([@B15]), STF-62247 ([@B53]) and guttiferone K ([@B60]) are capable of regulating cancers via the autophagic cell death mechanism ([@B6]; [@B30]). Although clinically approved agents such as rapamycin, plays a therapeutic role in cancer therapy ([@B42]; [@B16]; [@B25]; [@B7]; [@B28], [@B27]; [@B63]; [@B58]), mTOR inhibition has adverse effects in protein synthesis, cell proliferation, and immune function ([@B29]; [@B44]). Therefore, drugs that can enhance autophagic cell death, especially in apoptosis-resistant cells, with minimal side effects would be highly desirable.

Our previous findings have identified a group of natural alkaloid small-molecules, including liensinine, isoliensinine, dauricine, and cepharanthine, which stimulated the induction of autophagy and autophagic cell death in a panel of apoptosis-resistant cells ([@B27]). Dauricine, the major bioactive alkaloid isolated from *Menispermum dauricum* D.C. ([@B21]), has been widely prescribed to treat inflammatory diseases ([@B62]), allergy, and arrhythmia in the local Chinese community. The reported pharmacological effect of dauricine has been attributed to its anti-arrhythmic effect and the ability to modulate Ca^2+^ and several K^+^ channels. ([@B64]). Based on spectrometric analysis and *N*-methylation method which offered the derivative of (dauricine dimethiodide), *N*-desmethyldauricine (LP-4) were firstly isolated from nature in [@B45] with unknown biological effects.

It was reported that cell differentiation, contraction of muscle, gene transcription and cell death are highly regulated by the change in cytosolic calcium level ([@B2]). Although the role of calcium regulating autophagy remains controversial, several literatures reported the calcium mobilizing agents such as alisol B, thapsigargin, ATP, vitamin D3 and ionomycin activated autophagy via the calcium-activated kinase (CAMKK)-β-AMPK- mTOR pathway ([@B17]; [@B28]). With the critical role of calcium involved in cellular signaling pathways responsible for tumorigenesis, alternating the homeostasis of calcium lead to cancers ([@B37], [@B36]; [@B47]), therefore, the potential role of calcium-regulated autophagy in modulating pathogenesis of cancers worth our further investigation. Upon cellular stressful conditions such as deprivation of nutrient, infection, accumulation of unfolded or misfolded proteins, stimulation by hypoxia, toxins or oxidative injury, and aberrant regulation on calcium level, UPR will be triggered to restore the normal function of ER. Autophagy has been emerged as an important cellular protective mechanism during ER stress ([@B48]).

In our current study, we report for the first time that LP-4, inhibits SERCA, leading to calcium release and induction of autophagy via the ULK and CaMKK-β-AMPK-mammalian target of rapamycin (mTOR)-dependent pathway. As one of the key mechanistic pathway triggering the induction of autophagy, we show that LP-4 causes Ca^2+^ release in cells and induces the UPR. By computational virtual docking analysis and biochemical assays, we demonstrate that LP-4 inhibits SERCA in a dose dependent manner which is co-incident with the concentrations leading to autophagic cell death in a panel of cancer cells, apoptosis-defective, and apoptosis-resistant cells. Our study provides pharmacological insights into the protective mechanism of LP-4 in its potential anti-cancer therapeutic application, and proposes a new direction of identifying novel autophagic inducers from natural products as a new therapeutic perspective for treating apoptosis-resistant cancers.

Materials and Methods {#s1}
=====================

Antibodies, Plasmids, Chemicals, and Reagents
---------------------------------------------

Unless otherwise specified, all chemicals and reagents were obtained from Sigma--Aldrich. BAPTA/AM (BM), compound C (CC), E64D, pepstatin A, thapsigargin, inositol trisphosphate, STO-609 and AMD3100 were purchased from Calbiochem (San Diego, CA, United States). *N*-desmethyldauricine (\>98% purity, HPLC) were purchased from the China Chengdu Biotechnology Company Ltd (Chengdu, China). Antibodies against AMPK, phospho-AMPKα (Thr172), p70S6 kinase, phospho-p70S6 kinase (Thr389), LC3B, PERK, eIF2α and phospho-eIF2α (Ser51) were purchased from Cell Signaling Technologies Inc. (Beverly, MA, United States). Antibodies against CXCR4, IgF-1, p62, and ULK-1 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, United States). Antibodies against beta-actin were obtained from Sigma (St. Louis, MO, United States). Antibodies against phospho-PERK (Thr980) were purchased from BioLegend (San Diego, CA, United States). TRITC-conjugated anti-mouse secondary antibodies (ZyMax^TM^) were purchased from Invitrogen (Scotland, United Kingdom). siRNAs targeting IgF-1, ULK-1, PERK, and non-silencing negative control siRNA (AllStars) were obtained from Qiagen (Hilden, Germany). pEGFP-LC3 reporter plasmid was provided by Prof. Tamotsu Yoshimori (Osaka University, Japan).

Cell Culture
------------

Unless otherwise specified, all cells were obtained from the American Type Culture Collection, ATCC (Rockville, MD, United States). Caspase 3/7-deficient and wild-type MEFs were generous gift provided by Prof. Richard A. Flavell (Yale University School of Medicine, United States). Bax-Bak double knockout MEFs were provided by Prof. Shigeomi Shimizu (Tokyo Medical and Dental University, Medical Research Institute, Japan). Caspase 8-deficient MEFs were generous gift from Prof. Kazuhiro Sakamaki (Kyoto University, Graduate School of Biostudies, Japan). Both Atg7 wild-type and deficient MEFs were gifts from Prof. Masaaki Komatsu (Juntendo University, School of Medicine, Japan). All cells were maintained in culture medium supplemented with 10% fetal bovine serum, penicillin (50 U/ml) and streptomycin (50 μg/ml) (Invitrogen, Paisley, Scotland, United Kingdom) at 37°C with 5% CO~2~.

Quantification of Green Fluorescent (GFP) LC3 Puncta Formation
--------------------------------------------------------------

Cells transfected with EGFP-LC3 were treated with LP-4 (10 μM) and then fixed with 4% of paraformaldehyde (Sigma). The formation of EGFP-LC3 puncta was exanimated and quantitated by fluorescent microscopic analysis (Applied Precision DeltaVision Elite, Applied Precision, Inc., United States) following autophagy guidelines ([@B24]). In brief, the number of cells with increased EGFP-LC3 fluorescence puncta (≥10 dots/cell) over the total number of EGFP-positive cells were calculated. For each experiment, a minimum of 1000 cells from randomly selected fields were scored.

Detection of Cytotoxicity and Apoptosis
---------------------------------------

Cell cytotoxicity assay was used to measure cell viability (IC~50~ value). In brief, the percentage of cell viability was calculated as: Cells number~treated~/Cells number~DMSO\ control~ × 100. Annexin V (BD Biosciences, San Diego, CA, United States) stained cells were measured by FACSAria III flow cytometer (BD Biosciences) to detect apoptosis. Data obtained from three independent experiments were analyzed by using CellQuest (BD Biosciences).

Transmission Electron Microscopy
--------------------------------

In brief, cells were first fixed overnight with 2.5% of glutaraldehyde, and then post-fixed in 1% of OsO4 before embedded in Araldite 502 for microscopy. Ultrathin sections stained with uranyl acetate and lead citrate were then analyzed by transmission electron microscope (Philips CM100) at a voltage of 80 kV.

PCR Array Analysis
------------------

Total RNA were obtained by using Qiagen RNeasy^®^ Mini Kit (Qiagen). cDNA was synthesized by performing reverse transcription using RT^2^ first strand kit (Qiagen). The human autophagy pathway specific RT^2^ Profiler PCR array (Qiagen), comprises of 87 autophagy related genes involved in regulating autophagy, was used to evaluate the potential mechanistic pathways of LP-4 in HeLa cells. Real-time PCR reactions were performed by using RT^2^ SYBR^®^ Green qPCR Mastermix (Qiagen) with the ViiA^TM^ 7 Real Time PCR System (Applied Biosystems). Integrated web-based software package (Qiagen) which calculated all ΔΔCt based fold-change from threshold cycle raw data was used for data analysis.

Intracellular Free Calcium Measurement
--------------------------------------

HeLa cells after treatment of LP-4 (5 or 10 μM) were washed twice with MEM. The cell suspensions were then stained with 5 μM of Fluo-3, a high sensitive fluorescent dye for rapid measurement of calcium flux in cells, at 37°C for 30 min. The cells were washed twice with HBSS before subjected to FACS analysis with at least 10,000 events measured.

Measurement of Cytoplasmic Calcium Dynamic
------------------------------------------

Intracellular cytosolic Ca^2+^ dynamic was measured using the FLIPR Calcium 6 Assay Kit (Molecular Devices) according to the manufacturer's instructions. In brief, HeLa cells were plated at a density of 10000 cells per well in black wall/clear bottom 96-multiwell plates from Costar (Tewksbury, MA, United States) and cultured for 24 h before treatment. After that, calcium 6 reagent was added directly to cells, and cells were incubated for an additional 2 h at 37°C and 5% CO~2~. 5 and 10 μM of LP-4 were then added to the wells and immediately subjected to data acquisition on the FLIPR Tetra High-Throughput Cellular Screening System (Molecular Devices) at room temperature using a 1-s reading interval throughout the experiments.

Single Cell Calcium Imaging
---------------------------

2 × 10^5^ HeLa cells were cultured in 35 mm confocal disk at 37°C CO~2~ incubator for 24 h. 5 mM of Fluo 3/AM/DMSO stock solution was diluted to 5 μM working solution using Hanks-balanced salt solution (HBSS) and then added to cells at 37°C for 30 min. HeLa cells were then washed three times with HEPES buffer saline and incubated at 37°C in an imaging chamber for another 10 min. Changes in cytosolic \[Ca^2+^\] levels were monitored by following changes in fluo-3 fluorescence upon addition of 10 μM LP-4 in HBSS buffer, using the real-time mode for 5 min by epifluorescence microscopy (Applied Precision DeltaVision Elite, Applied Precision, Inc., United States). Data Inspection Program provided by the DeltaVision software was used to measure the intensity of the fluo-3 fluorescence and the mean fluorescence intensity was monitored at 523 nm and plotted against time (sec).

Computational Docking
---------------------

The initial 3D structures for LP-4 were downloaded from the PubChem^[1](#fn01){ref-type="fn"}^. Then, the inhibitors were preprocessed by the LigPrep which uses OPLS-2005 force field and gave the corresponding low energy conformers of the compounds. The ionized state was assigned by using Epik at a target pH value of 7.0 ± 2.0. The co-crystal structure of sarco/endoplasmic reticulum Ca^2+^ ATPase (SERCA) complexed with thapsigargin (TG) was retrieved from the Protein Data Bank \[PDB ID code 2AGV ([@B40])\]. To prepare the protein for docking, the Protein Preparation Wizard module in Schrödinger 2009 was used to remove crystallographic water molecules, add hydrogen atoms, assign partial charges using the OPLS-2005 force field, assign protonation states, and minimize the structure. The minimization was terminated when the root-mean-square deviation (RMSD) reached a maximum value of 0.30 Å. In molecular docking, the prepared LP-4 was docked into the TG binding site of the SERCA using the Glide with the extra precision (XP) scoring mode. The docking grid box was defined using the Receptor Grid Generation tool in Glide by centering on TG in the SERCA. In molecular docking, 5000 poses were generated during the initial phase of the docking calculation, out of which best 1000 poses were chosen for energy minimization by 1000 steps of conjugate gradient minimizations. The best binding pose for LP-4 was considered for the further analysis.

Measurement of SERCA Activity
-----------------------------

The activity of Ca^2+^ ATPase (SERCA1A) purified from female rabbit hind leg muscle ([@B33]) was measured by using the enzymatic method utilizing pyruvate kinase and lactate dehydrogenase as described previously ([@B32]). In brief, all SERCA inhibition data were fitted to the allosteric dose vs. effect equation using Fig P (Biosoft, Cambridge, United Kingdom): Activity = minimum activity + (maximum activity - minimum activity)/(1 + (\[I\]/IC~50~)^P^).

Live-Cell Imaging
-----------------

After treatment with LP-4, the induction of autophagy was monitored in EGFP-LC3 transfected cells at 37°C supplied with 5% of CO~2~. Treated cells were then observed under oil objective (60× Olympus PlanApoN 1.42) at a wavelength of 512 nm. Under high magnification wide field epifluorescence microscopic analysis, DIC and fluorescent images were captured at 5-min intervals. Images were captured as serial Z-sections (1.0 μm interval) by using Olympus IX71-Applied Precision DeltaVision restoration microscope (Applied Precision, Inc., United States) equipped with Photometrics CoolSNAP HQ^2^ CCD camera. The epifluorescence images were numerically deconvolved by using DeltaVision algorithms (Applied Precision, Inc.).

Statistical Analysis
--------------------

The results were expressed as means ± SD as indicated. The differences were considered statistically significant when the *P*-value was less than 0.05. Student's *t*-test or one-way ANOVA analysis was used for comparison among different groups.

Results
=======

LP-4 Induces Autophagy and Cell Death toward Different Cancer Cell Lines
------------------------------------------------------------------------

Cytotoxicity of LP-4 (**Figure [1A](#F1){ref-type="fig"}**) was measured against cancer cells of different origins, including HeLa, MCF-7, PC3, HepG2, Hep3B, H1299, A549, LLC-1, and normal human hepatocytes (LO2). As shown in **Figure [1B](#F1){ref-type="fig"}**, LP-4 was more toxic in HepG2 liver cancer and H1299 lung cancer cells (mean IC~50~ \< 10 μM). However, the cytotoxicity of LP-4 was much lower in LO2 normal liver hepatocytes (mean IC~50~ = 62.1 μM), suggesting that LP-4 exhibited specific cytotoxic effects toward cancer cells.

![Autophagic activity of *N*-desmethyldauricine (LP-4). **(A)** Chemical structure of *N*-desmethyldauricine. **(B)** Cytotoxicity (IC~50~ value) of LP-4 on a panel of normal and cancerous cell line from different origins. **(C)** Detection of EGFP-LC3 in LP-4 treated cells. HeLa cells transfected with the EGFP-LC3 plasmid for 24 h were treated with DMSO (Control) or LP-4 (10 μM) for 4 h. Representative images showing the formation of EGFP-LC3 puncta were captured. Autophagic activity was defined by the number of cells with increased EGFP-LC3 fluorescence puncta (≥10 dots/cell) over the total number of EGFP-positive cells. Approximately 1000 EGFP-positive cells were scored for each treatment. Data were represented as the means of three independent experiments; error bars, SD ^∗∗∗^*P* \< 0.001. **(D)** The detection of LP-4 induced autophagy in both cancerous and normal cells. A panel of cancer cells including MCF-7, Hep3B, PC3, HepG2, LLC-1, A549 and normal liver cells (LO2) transfected with the EGFP-LC3 plasmid for 24 h were treated with LP-4 (10 μM) for 4 h. Representative images were captured (60× magnification). Scale bar, 15 μm.](fphar-08-00388-g001){#F1}

The induction of autophagy may lead to autophagic cell death in some apoptosis-resistant cancers through the inhibition of anti-autophagic proteins ([@B9]), thus, identification of novel autophagy inducers from natural products may act as an effective strategy for the discovery of anti-cancer compounds ([@B54]). To evaluate the autophagic effect of LP-4, the conversion of cytosolic LC3-I to membrane-bound LC3-II, an essential step for the induction of autophagy, was monitored by transiently expressing HeLa cells with GFP-LC3 protein ([@B26]; [@B50]). As revealed by the increased formation of GFP-LC3 puncta in HeLa cells, the result indicated that LP-4 could significantly induce autophagy (**Figure [1C](#F1){ref-type="fig"}**). To determine whether LP-4 could induce autophagy in other cancer and normal cell types, MCF-7, Hep3B, PC3, HepG2, LLC-1, A549 and normal human hepatocytes, LO2 were used. As shown in **Figure [1D](#F1){ref-type="fig"}**, LP-4 induced GFP-LC3 puncta formation in both normal and cancer cells, suggesting that the autophagic effect of LP-4 is not cell types specific. We further analyzed the ultra-structures of HeLa cells treated with LP-4 using transmission electron microscopy. As shown in **Figure [2A](#F2){ref-type="fig"}**, the number of double-membrane autophagosomes increased in a time-dependent manner in response to LP-4 treatments. Autophagic vacuoles (autolysosomes) with engulfed organelles were also identified in cells treated with LP-4 for 16 h (**Figure [2A](#F2){ref-type="fig"}**). As autophagosome accumulation could result from either an induction of autophagic flux or the blockage of fusion between autophagosome and lysosome ([@B35]; [@B29]), we measured the formation of LC3-II in the presence of lysosomal protease inhibitors (E64d and pepstatin A) ([@B27]). As shown in **Figure [2B](#F2){ref-type="fig"}**, LP-4 increased the rate of LC3-II formation in the presence of the protease inhibitors when compared with the addition of either protease inhibitors or LP-4 alone. These findings confirmed that LP-4 induced autophagy as a result of increased formation of autophagosome.

![*N*-desmethyldauricine (LP-4) induces autophagy through an Atg7 dependent mechanism. **(A)** LP-4 induced the formation of autophagosomes/autolysosome in cells. After the treatment of LP-4 (10 μM), the changes of the ultra-structures of HeLa cells were captured and showed as electron micrographs (40000× magnification). The highlighted red regions represented the magnified images of the double-membraned autophagosomes (red arrow), autolysosomes (yellow arrow) and engulfed organelles (blue arrow), respectively. **(B)** LP-4 induced autophagic flux. HeLa cells treated with LP-4 (10 μM) in the presence or absence of 10 μg/mL lysosomal protease inhibitors (E64d and Pepstatin A) for 24 h. Cell lysates were analyzed by western blot for LC3-II conversion (LC3-I, 18 kDa; LC3-II, 16 kDa), and actin, respectively. **(C)** LP-4 induced autophagy through an Atg7 dependent mechanism. Both Atg7 -wild-type (Atg7^+/+^) and -deficient (Atg7^-/-^) MEFs transfected with EGFP-LC3 plasmid were treated with LP-4 (10 μM) for 4 h. Autophagic activity was evaluated as the number of cells with increased EGFP-LC3 fluorescence puncta (≥10 dots/cell) over the total number of EGFP-positive cells. Data was represented as the means of three independent experiments; scale bar, 15 μm; error bars, SD ^∗∗∗^*P* \< 0.001.](fphar-08-00388-g002){#F2}

LP-4 Induces Autophagy Dependent on Autophagy-Related Gene (Atg) 7
------------------------------------------------------------------

The elongation of the autophagosomal membrane is highly regulated by the ubiquitin-like conjugation systems ([@B41]). For example, the conjugation of Atg12 to Atg5 requires the ubiquitin-activating-enzyme-like Atg7 and Atg10 ([@B22]), which are essential for autophagic vesicle nucleation and elongation ([@B29]). To study the role of Atg7 in LP-4-induced autophagy, we over-expressed the GFP-LC3 plasmids in both Atg7 wild-type and deficient MEFs. Results indicated that LP-4 induced the formation of GFP-LC3 puncta in Atg7 wild-type MEFs, the percentage of cells with GFP-LC3 puncta formation was very low in Atg7 deficient MEFs, which are resistant to autophagy induction (**Figure [2C](#F2){ref-type="fig"}**). This result indicated the involvement of Atg7 in LP-4-mediated induction of autophagy.

LP-4 Induces Autophagy through Up-regulation of ULK-1 and PERK Gene Expression
------------------------------------------------------------------------------

To study the autophagic genes that may be responsible for the induction of autophagy by LP-4, real time PCR array, which contains 87 candidate genes associated with autophagy was used. Scatter plot of genes array data showed that LP-4 up-regulated the Igf1, Fam176a, Ulk-1, PERK, Cxcr4, and Sqstm1 (p62) genes (**Figure [3A](#F3){ref-type="fig"}**) in HeLa cancer cells. Consistently, further validation by western blot showed that protein level of Cxcr4, p-PERK, IgF-1, Sqstm1 (p62), and Ulk-1 were increased after LP-4 treatments (**Figure [3B](#F3){ref-type="fig"}**) and there was an increased phosphorylation on the downstream target of PERK, the eIF2-α ([@B20]) (**Figure [3B](#F3){ref-type="fig"}**, lower panel). Given the induction of autophagy can lead to the degradation of the autophagic substrate p62 ([@B3]), which is used for studying autophagic flux due to its binding ability to LC3 ([@B24]). In contrast, LP-4 induced the expression of p62 (**Figure [3B](#F3){ref-type="fig"}**). To this end, real-time PCR array was performed to analyze the transcription level of p62 mRNA after treatments of LP-4. Our results demonstrated that the increased protein level of p62 was caused by an up-regulation of the p62 mRNA level (**Figure [3A](#F3){ref-type="fig"}**). Therefore, results monitoring the autophagic flux by using p62 antibodies should be interpreted with cautions ([@B27]).

![*N*-desmethyldauricine (LP-4) induces autophagy-related genes expression in HeLa cancer cells. **(A)** Autophagic gene PCR array analysis of LP-4. HeLa cells treated with LP-4 (10 μM) for 24 h were extracted for RNA before performing reverse transcription for the synthesis of cDNA. Real-time PCR reactions were performed on the 96 well plate. Scatter plot highlighted the up- or down-regulation of autophagy related genes after LP-4 treatments. **(B)** LP-4-regulated protein expression was confirmed by Western blot. Cell lysates were detected for the expression of CXCR4, P-PERK, PERK, IgF-1, p62, ULK-1 and actin, respectively. Lower panel, protein expression of P-eIF-2α, eIF-2α and actin were detected after LP-4 (10 μM) or rapamycin (Ra, 300 nM, 24 h) treatments. **(C)** Activation of PERK and ULK-1 was involved in the LP-4-regulated induction of autophagy. HeLa cells transfected with *si*RNA negative control, PERK, IgF-1 or ULK-1 *si*RNA with EGFP-LC3 plasmid for 48 h, were treated with LP-4 (10 μM) for a further 4 h before subjecting to fluorescence microscopic analysis. Bar chart represented the quantitation of autophagic cells. **(D)** CXCR4 was not required for LP-4 mediated induction of autophagy. HeLa cells transfected with EGFP-LC3 were treated with LP-4 (10 μM) in the presence of 25mg/mL CXCR4 specific inhibitor (AMD 3100) for 4 h. Bar chart indicated the autophagic activity of LP-4. The expression of LC3-II after LP-4 and AMD 3100 treatments were confirmed by Western blot. Error bars, SD ^∗∗∗^*P* \< 0.001.](fphar-08-00388-g003){#F3}

We then validated the involvement of IgF ([@B11]), PERK ([@B11]), and Ulk-1 ([@B38]) in LP-4-mediated autophagy through *siRNA* knockdown experiments. Knockdown of either PERK or Ulk-1 genes decreased the percentage of cells with GFP-LC3 puncta formation, whereas knockdown of IgF did not affect the percentage of cells with GFP-LC3 puncta formation significantly (**Figure [3C](#F3){ref-type="fig"}**). Furthermore, the induction of autophagy by LP-4 was not abolished by the addition of Cxcr4 inhibitor (AMD3100; **Figure [3D](#F3){ref-type="fig"}**) ([@B14]). These results suggested that LP-4 may induce autophagy through the Ulk-1 and PERK dependent pathways, and did not involve Cxcr4 gene.

LP-4 Induces Autophagy via the AMPK-mTOR Pathway
------------------------------------------------

Extensive studies have shown that autophagy is promoted by AMPK, which is an energy sensor responsible for regulating cellular metabolism or energy homeostasis under low intracellular ATP conditions such as nutrient deprivation or hypoxia, through the AMPK-mTOR-dependent pathway ([@B23]). As shown in **Figure [4A](#F4){ref-type="fig"}**, there was a time-dependent increase in the phosphorylation of AMPK after treatments of LP-4. As a downstream target of mTOR, the phosphorylation of p70S6K was also decreased after LP-4 treatments (**Figure [4A](#F4){ref-type="fig"}**). The involvement of AMPK in LP-4-induced autophagy was further confirmed by the addition of AMPK inhibitor (compound C). As shown in **Figure [4B](#F4){ref-type="fig"}**, a reduction in the percentage of cells with GFP-LC3 puncta formation was observed in cells treated with both compound C and LP-4. The results suggested that LP-4 induces autophagy via the AMPK-mTOR dependent signaling cascade.

![*N*-desmethyldauricine (LP-4) induces autophagy via CaMKK-β -AMPK -mTOR signaling pathways. **(A)** LP-4 activated the AMPK-mTOR cascade. Cells treated with LP-4 (10 μM) or positive control (rapamycin, 300 nM) for 24 h was analyzed for the expression of p-p70S6K, total p70S6K, p-AMPK, AMPK, and actin by Western blot. **(B)** Inhibitors for AMPK, CaMKK-β and calcium chelator inhibited autophagy induction by LP-4. EGFP-LC3 transfected HeLa cells were treated with DMSO (Ctrl) or LP-4 (10 μM) in the presence or absence of AMPK inhibitor compound C (CC, 10 μM), CaMKK β inhibitor (STO-609, 25 μM) or calcium chelator, BAPTA/AM (BM, 10 μM) for 4 h. The cells were then fixed for fluorescence microscopic analysis and quantitation of autophagic cells. **(C)** Compound C, STO-609 and BAPTA/AM inhibited the conversion of LC3-II in HeLa cells. Cells treated with LP-4 (10 μM) with or without the presence of compound C (CC, 10 μM), STO-609 (25 μM) or BAPTA/AM (10 μM) for 4 h were analyzed for the protein expression of LC3-II (LC3-I, 18 kDa; LC3-II, 16 kDa). **(D)** Calcium chelator (BAPTA/AM) suppressed the cell death induced by LP-4 in HeLa. Cells treated with LP-4 (10 μM) with the presence of BAPTA/AM (BM, 2.5 μM) for 24 h were subjected to flow cytometry analysis after annexin V staining. Bar chart indicated the percentage of apoptotic cells after treatments. Data were the means of three independent experiments; error bars, *SD* ^∗∗∗^*P* \< 0.001; scale bar, 15 μm.](fphar-08-00388-g004){#F4}

On the other hand, Ca^2+^ mobilizing agents can also lead to the activation of autophagy via the CaMKKβ-AMPK-mTOR signaling pathway ([@B17]). To this end, HeLa cells were treated with LP-4 with the addition of the CaMKK-β inhibitor (STO-609) ([@B51]) or the intracellular Ca^2+^ chelator (BAPTA/AM, BM). As shown in **Figure [4B](#F4){ref-type="fig"}**, both STO-609 and BAPTA/AM could reduce the percentage of cells with GFP-LC3 puncta formation (**Figure [4B](#F4){ref-type="fig"}**), suggesting the possible role of calcium in regulating LP-4-induced autophagy. In the presence of compound C, STO-609 or BAPTA/AM, the protein level of LC3-II were reduced upon treatments of LP-4 (**Figure [4C](#F4){ref-type="fig"}**). Consistently, the presence of BAPTA/AM, BM resulted in significantly lower cytotoxicity in cells after LP-4 treatments (**Figure [4D](#F4){ref-type="fig"}**). Taken together, the results suggested the involvement of calcium in LP-4 mediated autophagy and cytotoxicity.

LP-4 Induces Autophagy via An Increase in the Level of Cytosolic Calcium \[Ca^2+^\]
-----------------------------------------------------------------------------------

To further confirm the role of calcium in LP-4-mediated induction of autophagy, the cytosolic \[Ca^2+^\] levels of HeLa cells were measured by flow cytometry. As shown in **Figure [5A](#F5){ref-type="fig"}**, HeLa cells incubated with LP-4 showed a dose- and time-dependent increase in fluorescence signal as revealed by the staining of Fluo 3, a highly sensitive dye for measurement of calcium in cells. Consistently, FLIPR Calcium 6 assay further demonstrated that the LP-4 dose-dependently induced calcium dynamic change in HeLa cancer cells (**Figure [5B](#F5){ref-type="fig"}**). Furthermore, single live-cell Ca^2+^ imaging was monitored and results showed that HeLa cells loaded with Fluo 3-AM displayed a dramatic increase in fluorescence intensity upon LP-4 (10 μM) treatment (**Figure [5C](#F5){ref-type="fig"}** and Supplementary Video-3). Since the inhibition of the SERCA pump can lead to the induction of autophagy through calcium homeostasis ([@B17]), the molecular interactions between LP-4 and SERCA were then predicted by computational virtual ligand docking analysis. As revealed by the comparative analysis of the low-energy ligand conformations (**Figure [5D](#F5){ref-type="fig"}**), the preferred binding site for LP-4 is close to the binding site of a well-known inhibitor of SERCA, thapsigargin (TG), which induces autophagy through elevating intracellular calcium level in cells ([@B18]). Furthermore, as shown by the predicted binding pose of LP-4 (**Figure [5D](#F5){ref-type="fig"}**), the hydrophobic groups bind into the hydrophobic pocket, making favorable hydrophobic effects and van der Waals interactions with residues Phe256, Leu260, Val263, Leu266, Ile267, Ala270, Ala305, Ala306, Pro308, Ile756, Ile761, Val769, Val772, Val773, Phe776, Leu777, Pro827, Leu828, Ile829, Phe834, Met838, Gly841, and Gly842, suggesting the structures of LP-4 docked into the SERCA binding site of TG. Comparison of the docking score of LP-4 (-8.97 kcal/mol) with TG (-7.23 kcal/mol) indicated that both compounds were located within the SERCA binding pocket.

![*N*-desmethyldauricine (LP-4) mobilizes cytosolic calcium in HeLa cells. **(A)** LP-4 dose- and time- dependently increased the cytosolic calcium level in HeLa cancer cells. HeLa cells treated with LP-4 (10 μM) were subjected to flow cytometry analysis after staining of Fluo-3. Representative FACS charts indicating the intracellular calcium level of cells were showed. Bar charts represented the percentage of calcium release in cells; error bars, SD ^∗∗∗^*P* \< 0.001. **(B)** LP-4 induced calcium dynamic change in HeLa. HeLa cells stained with FLIPR Calcium 6 Assay Kit were treated with 5 and 10 μM of LP-4, then immediately subjected to calcium dynamic measurement by FLIPR Tetra High-Throughput Cellular Screening System. Data from the chart represents mean values ± SD of three independent experiments. **(C)** LP-4 mobilized cytosolic calcium level in HeLa cells. HeLa cells seeded in 35 mm confocal disk were incubated with 5 μM of Fluo 3/AM in HBSS buffer at 37°C for 30 min. Cells were then washed with HEPES buffer saline and incubated at 37°C for another 10 min. Calcium signal was monitored by Applied Precision DeltaVision Elite in real-time mode for consecutive 3 min during the addition of 10 μM LP-4 in HBSS buffer. Chart represents the mean intensity of fluorescence signal at 523 nm. **(D)** Computation docking of SERCA pump with LP-4. The SERCA protein was represented as carton. Key residues around the binding pocket were shown as lines and the LP-4 was presented as sticks. The hydrogen bonds were labeled as red dashed lines. Extra precision (XP) scoring for thapsigargin and LP-4 were --7.23 and --8.97, respectively. **(E)** LP-4 inhibited the activity of SERCA in skeletal muscle SR. The enzymatic assay and all measurements were performed at 25°C (pH 7.2) ([@B28]).](fphar-08-00388-g005){#F5}

To further validate the computational docking results, the effect of LP-4 on the activity of SERCA1A isoform was evaluated by using purified rabbit skeletal muscle sarcoplasmic reticulum (SR) membranes ([@B59]). As shown in **Figure [5E](#F5){ref-type="fig"}**, although SERCA activity was inhibited by LP-4 in a dose-dependent manner, the IC~50~ value of LP-4 was very high, appropriately 100 μM, which suggested that LP-4 is a weak SERCA inhibitor.

LP-4 Induces Autophagic Cell Death in Apoptosis-Resistant Cancer Cells
----------------------------------------------------------------------

Although autophagy can act as a tumor-suppression mechanism, it is also a mechanism for stress tolerance which may sustain cancer cells viability under adverse conditions and promote pathogenesis of cancers ([@B57]). To investigate the LP-4-mediated cell death mechanism, both Atg7 wild-type and deficient MEFs treated with LP-4 were subjected to annexin V flow cytometry analysis. As shown in **Figure [6A](#F6){ref-type="fig"}**, LP-4 possessed significantly higher cytotoxicity in Atg7 wild-type MEFs (c.a. 70% of cell death upon 10 μM LP-4 treatment), when compared to Atg7 deficient MEFs (c.a. 10% cell death upon 10 μM LP-4 treatment). As the failure of the induction of autophagy in Atg7^-/-^ deficient MEFs could lead to a significant decrease in the percentage of cell death, therefore, it was suggested that LP-4 may lead to autophagic cell death. We further investigated the cytotoxic potency of LP-4 toward a panel of apoptosis -resistant or -defective cells, including caspase -3/-7/-8/ deficient MEFs, caspase-3/-7 double knockout (DKO) MEFs and Bax-Bak DKO MEFs. Our results demonstrated that LP-4 displayed no significant difference in the cytotoxicity effect (IC~50~ value) toward the panel of selected apoptosis -resistant or -defective cells (**Figure [6B](#F6){ref-type="fig"}**). The data supported our postulation that LP-4 could induce autophagic cell death that is independent of the apoptosis pathway.

![*N*-desmethyldauricine (LP-4) induces autophagic cell death in apoptosis resistant cells. **(A)** Cell death measurement (%) in Atg7- wild-type and -deficient MEFs after LP-4 treatment. **(B)** Cytotoxicity (IC~50~ value) of LP-4 in caspase WT/-3/-7/-8, caspase -3 and -7 DKO, Bax-Bak DKO -wild-type and -deficient MEFs. These panel of MEFs were incubated with LP-4 (0.19--100 μM) for 3 days. MTT assay were performed to evaluate the mean IC~50~ of LP-4. **(C)** BAPTA/AM inhibited the autophagic effect of LP-4 in apoptosis-resistant cells. Bax-Bak DKO deficient MEFs were treated with 10 μM of LP-4 in the presence of calcium chelator, BAPTA/AM (BM, 10 μM), for 4 h. The cells were then fixed and incubated with anti-LC3B and TRITC-conjugated secondary antibodies before fluorescence microscopic analysis. **(D,E)** Live-cell imaging of LP-4-induced autophagic cell death. Cells transfected with EGFP-LC3 were treated with 10 μM of LP-4. Cells were then placed inside the 37°C imaging chamber supplied with 5% of CO~2~ for monitoring of autophagy and autophagic cell death. Live-cell fluorescent and bright field images were captured for 4 h with 10 min time-intervals. Yellow arrows indicated autophagy induction with EGFP-LC3 accumulation; Red arrows indicated autophagic cell death. ^∗∗∗^*P* \< 0.001.](fphar-08-00388-g006){#F6}

In fact, the use of autophagy inducers to induce autophagic cell death in apoptosis -resistant cells has been considered as an effective alternative approaches in treating cancers ([@B1]). To confirm whether LP-4 could induce autophagy via the mobilization of calcium in apoptosis-resistant cells, Bax-Bak DKO MEFs treated with LP-4 were incubated with calcium chelator (BAPTA/AM) and then subjected to immunofluorescence staining. As demonstrated by a significant decrease of fluorescent endogenous LC3B signal (**Figure [6C](#F6){ref-type="fig"}**), the chelation of calcium by BAPTA/AM abolished LP-4 induced autophagy. This result suggested that LP-4 is able to mobilize calcium release, which induces autophagy in apoptosis-resistant cells. Furthermore, the induction of autophagy and autophagic cell death by LP-4 in HeLa and Bax-Bak DKO apoptosis-resistant MEFs were monitored by live cell imaging (**Figures [6D,E](#F6){ref-type="fig"}** and Supplementary Videos-1, 2).

To investigate the role of autophagy in LP-4-mediated cell death in cancer, DLD-1 Bax-Bak DKO apoptosis-resistant colon cancer cells treated with LP-4 and calcium chelator (BAPTA/AM) were subjected to annexin V flow analysis. While LP-4 markedly induced autophagic cell death in Bax-Bak DKO apoptosis-resistant cancer cells, BAPTA/AM significantly suppressed the LP4-induced cell death (**Figure [7A](#F7){ref-type="fig"}**). Concomitantly, LP-4 alone markedly stimulated the calcium dynamic change in DLD-1 Bax-Bak DKO cancer cells, whereas addition of calcium chelator, BAPTA/AM completely suppressed the LP-4-mediated calcium flux in these apoptosis-resistant cancer cells (**Figure [7B](#F7){ref-type="fig"}**). Collectively, these data suggested that LP-4 could induce cell death through autophagy in apoptosis-resistant cancer cells via calcium mobilization. In p53 knockout apoptosis-resistant cancer cells, taxol and etoposide known for inducing cancer cell death via the p53 pathway independent of autophagy ([@B61]; [@B46]), the differences in their mean IC~50~ value between the p53-deficient and wild-type HCT-116 cells were significantly higher (14.45- and 3.14-fold) (**Figure [7C](#F7){ref-type="fig"}**). In contract, LP-4 showed a mean IC~50~ value of 23.2 μM in wild-type HCT 116 p53^+/+^ compared to 30.2 μM in HCT 116 p53^-/-^ cells, respectively, demonstrating merely 1.3-fold differences in cytotoxicity (**Figure [7C](#F7){ref-type="fig"}**). Concomitantly, addition of BAPTA/AM markedly recovered the cell death from LP-4 treatment in p53-deficient HCT-116 cancer cells (**Figure [7D](#F7){ref-type="fig"}**). These results suggested that LP-4-mobilized calcium release may circumvent the apoptosis-resistant phenotype of cancer cells caused by genetic deficiency in p53 gene.

![*N*-desmethyldauricine (LP-4) induces autophagic cell death in apoptosis resistant cancer cells. **(A)** BAPTA/AM inhibited cell death induced by LP-4 in apoptosis-resistant cancer cells. DLD-1 Bax-Bak DKO colon cancer cells treated with LP-4 (30 μM) in the presence of 10 μM of BAPTA/AM for 24 h were assayed by flow cytometry after annexin V staining. **(B)** BAPTA/AM abolished the LP-4-induced calcium dynamic change in apoptosis-resistant cancer cells. DLD-1 Bax-Bak DKO colon cancer cells stained with FLIPR Calcium 6 Assay Kit were treated with 30 μM of LP-4, with or without pretreatment of BAPTA/AM (10 μM), then immediately subjected to calcium dynamic measurement by FLIPR Tetra High-Throughput Cellular Screening System. Data from the chart represents mean values ± SD of three independent experiments. **(C)** Drug-resistant effects of LP-4 on p53-deficient apoptosis-resistant cancer cells. HCT-116 p53 wild-type and deficient colon cancer cells were incubated with different concentrations of LP-4, taxol and etoposide for 3 days. Cytotoxicity of these compounds were measured by MTT assay and shown as the mean IC~50~. **(D)** BAPTA/AM recovered the cell death from LP-4 treatment in p53-deficient apoptosis-resistant cancer cells. HCT-116 p53-deficient colon cancer cells treated with LP-4 (10 μM) in the presence of 10 μM of BAPTA/AM for 24 h were assayed by flow cytometry after annexin V staining. ^∗∗∗^*P* \< 0.001.](fphar-08-00388-g007){#F7}

Discussion
==========

Autophagy plays an essential role in defense against cancers, neurodegenerative disorders, aging, and infectious diseases ([@B34]). Small-molecules that induce autophagy may have broad therapeutics applications. In our previous studies, we have identified several triterpenoid and alkaloid compounds as autophagic enhancers targeting apoptosis-resistant cells which can potentially be developed into new anti-cancer agents ([@B28]; [@B58]; [@B27]). Among these compounds, the triterpenoid saikosaponin-d (Ssd) and alisol B were found to directly inhibit SERCA, leading to release of cytosolic \[Ca^2+^\], and thereby induced autophagy and significant autophagic cytotoxicity upon various cancer cells. The natural alkaloid small-molecules, including liensinine, isoliensinine, dauricine, and cepharanthine, also stimulate the AMPK-mTOR dependent induction of autophagy and autophagic cell death in a panel of apoptosis-resistant cells. However, the role of cytosolic calcium level in such alkaloid-induced autophagic cytotoxicity is unclear and the resulted cell death-inducing effect appeared to be mild. In this study, we used a derivative of dauricine (*N*-desmethyldauricine/LP-4) to further verify the precise cellular machinery regulating the autophagic cell death. Derivatives of dauricine are of interest since dauricine has been shown *in vitro* to process anti-cancer property in colon ([@B62]), lung ([@B21]), breast ([@B49]), and urinary cancers ([@B55]). In fact, our previous findings point toward potential use of dauricine in multidrug- and apoptosis-resistant cancers intervention ([@B27]). Intriguingly, LP-4 demonstrated a better therapeutic effect than dauricine upon some experimental cancer models. For example, we previously found that, dauricine induced autophagic cell death with a higher IC~50~ value ([@B27]) toward the cell lines MCF-7 (28.7 μM) and A549 (40.4 μM), while the IC~50~ value corresponding to these cell lines upon LP-4 treatment are 1.8 to 2-fold lower as demonstrated in this report: MCF-7 (15.5 μM) and A549 (19.7 μM). Such higher cytotoxicity could be a result of the existence of the electrophilic quinone methide group on LP-4 ([@B56]; [@B21]). However, the molecular mechanisms for inducing the higher cellular toxicity as demonstrated might be attributed to increased autophagic effect (unpublished observation).

Thus far, information concerning the detail mechanisms underpinning LP-4 function is scarced, our pilot study here correlated LP-4 and the induction of autophagy via the manipulation of cytosolic Ca^2+^ concentration. We firstly demonstrated that LP-4 interacts with SERCA inhibiting the transfer of Ca^2+^ from cytoplasm to the ER lumen resulted in the accumulation of cytosolic Ca^2+^. Result collected from the FLIPR assay (**Figure [7B](#F7){ref-type="fig"}**) confirmed the capability of LP-4 in triggering Ca^2+^ release, since pretreatment of the calcium chelator BATA/AM abolished the calcium dynamics of our LP-4-treated Bax-Bak double knockout DLD-1 colon cancer cells. The increase in cytosolic level of Ca^2+^ further activates the calcium dependent kinase, CaMKK-β, for the activation of AMPK-mTOR signaling cascade (**Figure [4](#F4){ref-type="fig"}**) and subsequently induces autophagy as well as autophagic cell death in cancer cells. The cytotoxic effect of LP-4 significantly reduced when the apoptosis-resistant Bax-Bak double knockout DLD-1 colon cancer cells were receiving the same treatment (**Figure [7A](#F7){ref-type="fig"}**) consolidated that the LP-4-induced cytotoxicity is related to calcium-mediated autophagic cell death.

In contrast to the prominent Ca^2+^ mobilizing ability, the interaction between LP-4 and SERCA is comparatively weak (50% reduction of SERCA activity in response to 150 μM LP-4 treatment). Such observation implied that, LP-4 may also intervene with other calcium transporters which influence the localization of cytosolic Ca^2+^. Other possible coupling partners of LP-4 include the 1,4,5-trisphosphate receptor (InsP3R) and the RyRs localized in the SR/ER ([@B43]; [@B39]). The InsP3R is membrane glycoprotein complex which is an important Ca^2+^ channel responsible for the release of Ca^2+^ from intracellular pool upon inositol trisphosphate (InsP3) activation ([@B31]). InsP3R is critical to the regulation of various cellular processes, such as cell division, proliferation, apoptosis, and etc. ([@B4]). Of note, InsP3R-mediated release of Ca^2+^ from the ER has been reported during cellular starvation which leads to the upregulation of autophagy as a result of the elevated cytosolic Ca^2+^ level ([@B10]). Similar to the InsP3R, the RyRs constituting a family of Ca^2+^ release channels and mediate the release of calcium ions from the SR/ER. The RyRs channels are ubiquitously expressed in many types of cells and participate in a variety of vital Ca^2+^ signaling for maintaining cellular homeostasis ([@B13]). [@B5] demonstrated that one of the isoforms of RyRs, the RyR2, can act as proximal controllers of mitochondrial Ca^2+^, ATP levels, and a cascade of transcription factors controlling metabolism and survival via the regulation of Ca^2+^ fluxes. In addition, the loss of RyR2 receptor could induce a non-apoptotic form of programmed cell death associated with increased calpain-10 but not caspase-3 activation or ER stress ([@B5]). Another recent study also suggested the RyRs type 3 (RyR3) can trigger autophagic cell death in hippocampal neural stem cells via its regulatory function of ER Ca^2+^ mobilization ([@B8]). Together with our findings, targeting the Ca^2+^ signaling pathway by disrupting the cytosolic Ca^2+^ level to induce autophagic cell death in apoptosis- and drug-resistant cancers appeared to be a promising therapeutic strategy. Since, the normal molecular regulation of Ca^2+^ channels during tumorigenesis are generally hampered, cancer cells are more vulnerable to treatment associated with the alternation of Ca^2+^ mobilization owing to the loss of redundancy in Ca^2+^ channels ([@B12]). In line with this idea, we have showed that the use of LP-4 specifically induced cytotoxicity toward different cancer cells instead of the normal cellular counterpart (**Figure [1B](#F1){ref-type="fig"}**). It is worth notice that, such cancer-targeting cytotoxic effect of LP-4 may also be associated with the cell type-specific nature of autophagic functions. The molecular machineries operating in different cell types are varied, their crosstalk with the complex autophagy signaling pathways lead to the discrepancy in autophagy-induced cellular functions. Since, the molecular network constituting cancer cells and normal cells are different which may account for the specificity of the LP-4 drug action as illustrated in our data.

In summary, LP-4 induces cytotoxicity bypasses the apoptotic machinery and is associated with autophagy induction which leads to autophagic cell death. The LP-4-induced autophagy is mediated by the alteration of cytosolic Ca^2+^ level via the manipulation of cellular Ca^2+^ transportation system. Therefore, compounds which are capable of interfering with Ca^2+^ signaling are having the therapeutic potential for clinical application against cancers with phenotypes resistant to apoptosis and conventional chemotherapy. Findings acquired from this report also provided insight into and suggested an effective experimental platform for the search of other Ca^2+^ signaling modulators for refractory cancer therapy through autophagy upregulation.
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AMPK

:   AMP-activated protein kinase

Atg

:   autophagy-related gene

CaMKKβ

:   Ca^2+^/calmodulin-dependent kinase kinase-β

ER

:   endoplasmic reticulum

InsP~3~

:   inositol 1,4,5-trisphosphate

LC3

:   light-chain 3

LP-4

:   *N*-desmethyldauricine

MEFs

:   mouse embryonic fibroblasts

PERK

:   pancreatic ER kinase

Ryr

:   ryanodine receptor

SERCA

:   sarcoplasmic/endoplasmic reticulum Ca^2+^ ATPase pump

UPR

:   unfolded protein responses

3-MA

:   3-methyladenine
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